— Know what they know.
Not Investment Advice

MPLT NASDAQ

MapLight Therapeutics, Inc.
1W: -0.0% 1M: -8.9% 3M: +63.8% YTD: +74.6%
$28.75
-0.53 (-1.81%)
 
Weekly Expected Move ±13.4%
$21 $25 $29 $33 $36
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 38 · $22.7M mcap · 300289 float · 87.81% daily turnover · Short 87% of daily vol

Balance Sheet Trends

Total Assets
$480M +250.2% ▲
3Y CAGR: +130.0%
Total Liabilities
$21M -2.7% ▼
3Y CAGR: +4.5%
Shareholders Equity
$458M +297.9% ▲
3Y CAGR: +180.0%
Cash & Investments
$305M +180.4% ▲
3Y CAGR: +122.6%
Total Debt
$6M -11.8% ▼
3Y CAGR: -2.6%
Net Debt
-$41M -29.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$28M$80M$38M$47M
Short-Term Investments$0$0$71M$258M
Cash & ST Investments$28M$80M$109M$305M
Net Receivables$0$0$0$0
Inventory$0$0$0$0
Other Current Assets$4M$4M$0$20M
Total Current Assets$32M$84M$115M$325M
Property, Plant & Equip.$7M$7M$8M$7M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$234K$1M$12M$148M
Other Non-Current Assets$0$0$3M$59K
Total Non-Current Assets$7M$8M$22M$155M
Total Assets$39M$91M$137M$480M
— Liabilities —
Accounts Payable$0$0$2M$0
Short-Term Debt$348K$495K$778K$891K
Deferred Revenue$6M$4M$3M$0
Other Current Liabilities$5M$7M$6M$9M
Total Current Liabilities$13M$15M$16M$16M
Long-Term Debt$0$0$0$0
Other Non-Current Liab.$0$0$0$0
Total Non-Current Liabilities$6M$5M$6M$5M
Total Liabilities$19M$20M$22M$21M
— Equity —
Common Stock$0$0$0$5K
Retained Earnings-$66M-$122M-$199M-$361M
Accumulated OCI$0$0$163K-$228K
Total Stockholders Equity$21M$71M$115M$458M
Total Liabilities & Equity$39M$91M$137M$480M
— Key Metrics —
Total Debt$6M$6M$7M$6M
Net Debt-$21M-$74M-$32M-$41M
Total Investments$234K$1M$82M$407M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms